Biodexa Pharmaceuticals (BDRX) Exchange Rate Effect (2017 - 2021)
Biodexa Pharmaceuticals (BDRX) posted Exchange Rate Effect of -$8088.1 for Q4 2021, up 2.98% sequentially from -$8336.9 in Q3 2021, and down 103.21% YoY from $252206.1 in Q4 2020.
Biodexa Pharmaceuticals (BDRX) Exchange Rate Effect (2017 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported Exchange Rate Effect for 4 years, with the latest figure at -$8088.1 in Q4 2021.
- Quarterly Exchange Rate Effect fell 103.21% year-over-year to -$8088.1 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $476303.7 (up 33.76% YoY) and the FY2022 annual result came in at -$1237.6, up 88.76% from the prior year.
- Exchange Rate Effect rose to -$8088.1 in Q4 2021 per BDRX's latest filing, from -$8336.9 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $252206.1 in Q4 2020 and troughed at -$84857.8 in Q4 2019.
- A 4-year average of $56611.2 and a median of -$8212.5 in 2021 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2020 and 2021: Exchange Rate Effect surged 397.21% in 2020, then sank 103.47% in 2021.
- Over 4 years, Exchange Rate Effect stood at -$51778.9 in 2017, then plunged by 63.88% to -$84857.8 in 2019, then soared by 397.21% to $252206.1 in 2020, then slumped by 103.21% to -$8088.1 in 2021.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$8088.1, -$8336.9, and $252206.1 for Q4 2021, Q3 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -8,088.06 |
| Dec 31, 2021 | -8,088.06 |
| Sep 17, 2021 | -8,336.91 |
| Sep 17, 2021 | -8,336.91 |
| Dec 31, 2020 | 252,206.14 |
| Dec 31, 2020 | 252,206.14 |
| Sep 10, 2020 | 240,522.55 |
| Sep 10, 2020 | 240,522.55 |
| Dec 31, 2019 | -84,857.84 |
| Dec 31, 2019 | -84,857.84 |
| Dec 31, 2017 | -51,778.93 |
| Dec 31, 2017 | -51,778.93 |